Relationship-level analysis of drug users' anticipated changes in risk behavior following HIV vaccination

References

• Andersson, K. M., Owens, D. K., Vardas, E., Gray, G. E., McIntyre, J. A., & Paltiel, A. D. (2007). Predicting the impact of a partially effective HIV vaccine and subsequent risk behavior change on the heterosexual HIV epidemic in low- and middle-income countries: A South African example. Journal of Acquired Immune Deficiency Syndromes, 46(1), 78–90.
   PubMed Web of Science ®Google Scholar
• Baggaley, R. F., Boily, M.-C., White, R. G., & Alary, M. (2006). Risk of HIV-1 transmission for parenteral exposure and blood transfusion: A systematic review and meta-analysis. AIDS, 20, 805–812. doi:10.1097/01.aids.0000218543.46963.6d
   PubMed Web of Science ®Google Scholar
• Barrington, C., Moreno, L., & Kerrigan, D. (2008). Perceived influence of an HIV vaccine on sexual-risk behaviour in the Dominican Republic. Culture, Health & Sexuality, 10, 391–401. doi:10.1080/13691050801898877
   PubMed Web of Science ®Google Scholar
• Blower, S. M., Schwartz, E. J., & Mills, J. (2003). Forecasting the future of HIV epidemics: The impact of antiretroviral therapies & imperfect vaccines. AIDS Reviews, 5(2), 113–125.
   PubMedGoogle Scholar
• Boily, M.-C., Baggaley, R. F., Wang, L., Masse, B., White, R. G., Hayes, R. J., & Alary, M. (2009). Heterosexual risk of HIV-1 infection per sexual act: Systematic review and meta-analysis of observational studies. The Lancet infectious diseases, 9(2), 118–129. doi:10.1016/S1473-3099(09)70021-0
   PubMed Web of Science ®Google Scholar
• Crosby, R., & Holtgrave, D. (2006). Will sexual risk behaviour increase after being vaccinated for AIDS? International Journal of STD & AIDS, 17, 180–184. doi:10.1258/095646206775809204
   PubMed Web of Science ®Google Scholar
• Eaton, L. A., & Kalichman, S. C. (2007). Risk compensation in HIV prevention: Implications for vaccines, microbicides, and other biomedical HIV prevention technologies. Current HIV/AIDS Reports, 4, 165–172. doi:10.1007/s11904-007-0024-7
   PubMedGoogle Scholar
• Fonseca, M. G. P., Forsythe, S., Menezes, A., Vuthoori, S., Possas, C., Veloso, V., … Stover, J. (2010). Modeling HIV vaccines in Brazil: Assessing the impact of a future HIV vaccine on reducing new infections, mortality and number of people receiving ARV. PLoS ONE, 5(7), e11736–e11736. doi:10.1371/journal.pone.0011736.t003
   Google Scholar
• Gray, R. H., Li, X., Wawer, M. J., Gange, S. J., Serwadda, D., Sewankambo, N. K., … Quinn, T. C. (2003). Stochastic simulation of the impact of antiretroviral therapy and HIV vaccines on HIV transmission; Rakai, Uganda. AIDS, 17, 1941–1951. doi:10.1097/00002030-200309050-00013
   PubMed Web of Science ®Google Scholar
• Havens, J., Lofwall, M. R., Frost, S. D., Oser, C. B., Leukefeld, C. G., & Crosby, R. A. (2013). Individual and network factors associated with prevalent hepatitis C infection among rural Appalachian injection drug users. American Journal of Public Health, 103(1), e44–e52. doi:10.2105/AJPH.2012.300874
   PubMedGoogle Scholar
• Hogben, M., & Liddon, N. (2008). Disinhibition and risk compensation: Scope, definitions, and perspective. Sexually Transmitted Diseases, 35, 1009–1010.
   PubMed Web of Science ®Google Scholar
• Koniak-Griffin, D., Nyamathi, A., Tallen, L., González-Figueroa, E., & Dominick, E. (2007). Breaking the silence: What homeless 18- to 24-year-olds say about HIV vaccine trials. Journal of Health Care for the Poor and Underserved, 18, 687–698. doi:10.1353/hpu.2007.0061
   PubMed Web of Science ®Google Scholar
• MacPhail, C. L., Sayles, J. N., Cunningham, W., & Newman, P. (2012). Perceptions of sexual risk compensation following posttrial HIV vaccine uptake among young South Africans. Qualitative Health Research, 22, 668–678. doi:10.1177/1049732311431944
   PubMed Web of Science ®Google Scholar
• Newman, P., Lee, S. J., Duan, N., Rudy, E., Nakazono, T. K., Boscardin, J., … Cunningham, W. E. (2009). Preventive HIV vaccine acceptability and behavioral risk compensation among a random sample of high-risk adults in Los Angeles (LA VOICES). Health Services Research, 44, 2167–2179. doi:10.1111/j.1475-6773.2009.01039.x
   PubMed Web of Science ®Google Scholar
• Newman, P., Roungprakhon, S., Tepjan, S., Yim, S., & Walisser, R. (2012). A social vaccine? Social and structural contexts of HIV vaccine acceptability among most-at-risk populations in Thailand. Global Public Health, 7, 1009–1024. doi:10.1080/17441692.2012.692388
   PubMed Web of Science ®Google Scholar
• O'Connell, J. M., Hogg, R. S., Chan, K., Strathdee, S. A., McLean, N., Martindale, S. L., … Remis, R. (2002). Willingness to participate and enroll in a phase 3 preventive HIV-1 vaccine trial. Journal of Acquired Immune Deficiency Syndromes, 31, 521–528. doi:10.1097/00126334-200212150-00010
   PubMed Web of Science ®Google Scholar
• Olin, J., Kokolamami, J., Lepira, F. B., Mwandagalirwa, K., Mupenda, B., Ndongala, M. L., … Mokili, J. (2006). Community preparedness for HIV vaccine trials in the Democratic Republic of Congo. Culture, Health and Sexuality, 8, 529–544. doi:10.1080/13691050600888434
   PubMed Web of Science ®Google Scholar
• SAS Institute. (2011). The GLIMMIX procedure SAS/STAT 9.3 user's guide. Cary, NC: Author.
   Google Scholar
• Sayles, J. N., MacPhail, C. L., Newman, P., & Cunningham, W. E. (2010). Future HIV vaccine acceptability among young adults in South Africa. Health Education & Behavior, 37, 193–210. doi:10.1177/1090198109335654
   PubMed Web of Science ®Google Scholar
• Webb, P. M., Zimet, G. D., Mays, R., & Fortenberry, J. D. (1999). HIV immunization: Acceptability and anticipated effects on sexual behavior among adolescents. Journal of Adolescent Health, 25, 320–322. doi:10.1016/S1054-139X(99)00066-X
   PubMed Web of Science ®Google Scholar
• Wilde, G. J. (1982). The theory of risk homeostasis: Implications for safety and health. Risk Analysis, 2, 209–225. doi:10.1111/j.1539-6924.1982.tb01384.x
   Google Scholar
• Young, A. M., DiClemente, R. J., Halgin, D. S., Sterk, C. E., & Havens, J. R. (2014a). Drug users' willingness to encourage social, sexual, and drug network members to receive an HIV vaccine: A social network analysis. AIDS and Behavior, 18, 1753–1763. doi:10.1007/s10461-014-0797-9
   PubMed Web of Science ®Google Scholar
• Young, A. M., DiClemente, R. J., Halgin, D. S., Sterk, C. E., & Havens, J. R. (2014b). HIV vaccine acceptability among high-risk drug users in Appalachia: A cross-sectional study. BMC Public Health, 14(1), 537. doi:10.1186/1471-2458-14-537
   PubMed Web of Science ®Google Scholar
• Young, A. M., Halgin, D. S., DiClemente, R. J., Sterk, C. E., & Havens, J. R. (2014). Will HIV vaccination reshape HIV risk behavior networks? A social network analysis of drug users' anticipated risk compensation. PLoS One, 9(7), e101047. doi:10.1371/journal.pone.0101047
   Google Scholar
• Young, A. M., Jonas, A., Mullins, U., Halgin, D., & Havens, J. (2013). Network structure and the risk for HIV transmission among rural drug users. AIDS and Behavior, 17, 2341–2351. doi:10.1007/s10461-012-0371-2
   PubMed Web of Science ®Google Scholar